Literature DB >> 30713110

Multiplexed In Situ Imaging Mass Cytometry Analysis of the Human Endocrine Pancreas and Immune System in Type 1 Diabetes.

Yue J Wang1, Daniel Traum2, Jonathan Schug1, Long Gao1, Chengyang Liu3, Mark A Atkinson4, Alvin C Powers5, Michael D Feldman6, Ali Naji3, Kyong-Mi Chang2, Klaus H Kaestner7.   

Abstract

The interaction between the immune system and endocrine cells in the pancreas is crucial for the initiation and progression of type 1 diabetes (T1D). Imaging mass cytometry (IMC) enables multiplexed assessment of the abundance and localization of more than 30 proteins on the same tissue section at 1-μm resolution. Herein, we have developed a panel of 33 antibodies that allows for the quantification of key cell types including pancreatic exocrine cells, islet cells, immune cells, and stromal components. We employed this panel to analyze 12 pancreata obtained from donors with clinically diagnosed T1D and 6 pancreata from non-diabetic controls. In the pancreata from donors with T1D, we simultaneously visualized significant alterations in islet architecture, endocrine cell composition, and immune cell presentation. Indeed, we demonstrate the utility of IMC to investigate complex events on the cellular level that will provide new insights on the pathophysiology of T1D.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T1D; histopathology; human pancreas; imaging; imaging mass cytometry; immune cell composition; immunolabeling; islet structure; multiplexed imaging; spatial information; type 1 diabetes

Mesh:

Year:  2019        PMID: 30713110      PMCID: PMC6436557          DOI: 10.1016/j.cmet.2019.01.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  The diagnosis of insulitis in human type 1 diabetes.

Authors:  M L Campbell-Thompson; M A Atkinson; A E Butler; N M Chapman; G Frisk; R Gianani; B N Giepmans; M G von Herrath; H Hyöty; T W Kay; O Korsgren; N G Morgan; A C Powers; A Pugliese; S J Richardson; P A Rowe; S Tracy; P A In't Veld
Journal:  Diabetologia       Date:  2013-09-05       Impact factor: 10.122

2.  Epigenomic plasticity enables human pancreatic α to β cell reprogramming.

Authors:  Nuria C Bramswig; Logan J Everett; Jonathan Schug; Craig Dorrell; Chengyang Liu; Yanping Luo; Philip R Streeter; Ali Naji; Markus Grompe; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

3.  Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets.

Authors:  Talitha van der Meulen; Alex M Mawla; Michael R DiGruccio; Michael W Adams; Vera Nies; Sophie Dólleman; Siming Liu; Amanda M Ackermann; Elena Cáceres; Anna E Hunter; Klaus H Kaestner; Cynthia J Donaldson; Mark O Huising
Journal:  Cell Metab       Date:  2017-04-04       Impact factor: 27.287

4.  Multiplexed protein maps link subcellular organization to cellular states.

Authors:  Gabriele Gut; Markus D Herrmann; Lucas Pelkmans
Journal:  Science       Date:  2018-08-03       Impact factor: 47.728

5.  Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box.

Authors:  Mark A Atkinson
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

6.  The pancreatic polypeptide-rich lobe of the human pancreas: definitive identification of its derivation from the ventral pancreatic primordium.

Authors:  Y Stefan; S Grasso; A Perrelet; L Orci
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

7.  GABA and Artesunate Do Not Induce Pancreatic α-to-β Cell Transdifferentiation In Vivo.

Authors:  Amanda M Ackermann; Nicholas G Moss; Klaus H Kaestner
Journal:  Cell Metab       Date:  2018-07-26       Impact factor: 27.287

Review 8.  The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.

Authors:  Boris Calderon; Javier A Carrero; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2013-11-16       Impact factor: 7.486

9.  New perspectives on the microvasculature of the islets of Langerhans in the rat.

Authors:  S Bonner-Weir; L Orci
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

10.  α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.

Authors:  Marcela Brissova; Rachana Haliyur; Diane Saunders; Shristi Shrestha; Chunhua Dai; David M Blodgett; Rita Bottino; Martha Campbell-Thompson; Radhika Aramandla; Gregory Poffenberger; Jill Lindner; Fong Cheng Pan; Matthias G von Herrath; Dale L Greiner; Leonard D Shultz; May Sanyoura; Louis H Philipson; Mark Atkinson; David M Harlan; Shawn E Levy; Nripesh Prasad; Roland Stein; Alvin C Powers
Journal:  Cell Rep       Date:  2018-03-06       Impact factor: 9.423

View more
  73 in total

1.  The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.

Authors:  Ernesto S Nakayasu; Wei-Jun Qian; Carmella Evans-Molina; Raghavendra G Mirmira; Decio L Eizirik; Thomas O Metz
Journal:  Expert Rev Proteomics       Date:  2019-06-24       Impact factor: 3.940

2.  A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry.

Authors:  Nicolas Damond; Stefanie Engler; Vito R T Zanotelli; Denis Schapiro; Clive H Wasserfall; Irina Kusmartseva; Harry S Nick; Fabrizio Thorel; Pedro L Herrera; Mark A Atkinson; Bernd Bodenmiller
Journal:  Cell Metab       Date:  2019-01-31       Impact factor: 27.287

Review 3.  NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP).

Authors:  Klaus H Kaestner; Alvin C Powers; Ali Naji; Mark A Atkinson
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

4.  Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.

Authors:  Alice E Wiedeman; Virginia S Muir; Mario G Rosasco; Hannah A DeBerg; Scott Presnell; Bertrand Haas; Matthew J Dufort; Cate Speake; Carla J Greenbaum; Elisavet Serti; Gerald T Nepom; Gabriele Blahnik; Anna M Kus; Eddie A James; Peter S Linsley; S Alice Long
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 5.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

6.  Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry.

Authors:  Nikhil Singh; Zachary M Avigan; Judith A Kliegel; Brian M Shuch; Ruth R Montgomery; Gilbert W Moeckel; Lloyd G Cantley
Journal:  JCI Insight       Date:  2019-06-20

Review 7.  Engineering islets from stem cells for advanced therapies of diabetes.

Authors:  Johanna Siehler; Anna Karolina Blöchinger; Matthias Meier; Heiko Lickert
Journal:  Nat Rev Drug Discov       Date:  2021-08-10       Impact factor: 84.694

8.  Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression.

Authors:  Maria Fasolino; Naomi Goldman; Wenliang Wang; Benjamin Cattau; Yeqiao Zhou; Jelena Petrovic; Verena M Link; Allison Cote; Aditi Chandra; Michael Silverman; Eric F Joyce; Shawn C Little; Klaus H Kaestner; Ali Naji; Arjun Raj; Jorge Henao-Mejia; Robert B Faryabi; Golnaz Vahedi
Journal:  Immunity       Date:  2020-02-11       Impact factor: 31.745

Review 9.  Functional changes in beta cells during ageing and senescence.

Authors:  Cristina Aguayo-Mazzucato
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.122

Review 10.  Immune monitoring using mass cytometry and related high-dimensional imaging approaches.

Authors:  Felix J Hartmann; Sean C Bendall
Journal:  Nat Rev Rheumatol       Date:  2019-12-31       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.